EX-23.2 5 exhibit232-sx1.htm EX-23.2 Document
Exhibit 23.2
CONSENT OF THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Registration Statement on Form S-1 of our report dated July 16, 2021, relating to the financial statements of Pear Therapeutics, Inc. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
December 23, 2021